Gene · 2176
Papers2,586
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,586
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of germline cancer predisposition variants in pediatric sarcoma patients from somatic tumor testing. | Sci Rep | 2023 | 36805510 | PubTator, text mining | PubMed |
| Distinct genome-wide DNA methylation and gene expression signatures in classical monocytes from African American patients with systemic sclerosis. | Clin Epigenetics | 2023 | 36803404 | PubTator, text mining | PubMed |
| The hepato-ovarian axis: genetic evidence for a causal association between non-alcoholic fatty liver disease and polycystic ovary syndrome. | BMC Med | 2023 | 36800955 | PubTator, text mining | PubMed |
| Genomic Biomarkers Associated with Response to Induction Chemotherapy in Patients with Localized Pancreatic Ductal Adenocarcinoma. | Clin Cancer Res | 2023 | 36795432 | PubTator, text mining | PubMed |
| Association between human leukocyte antigen and immunosuppressive treatment outcomes in Chinese patients with aplastic anemia. | Front Immunol | 2023 | 36793734 | PubTator, text mining | PubMed |
| Discrimination between Complete versus Non-Complete Pathologic Response to Neoadjuvant Therapy Using Ultrasensitive Mutation Analysis: A Proof-of-Concept Study in BRCA1-Driven Breast Cancer Patients. | Int J Mol Sci | 2023 | 36768191 | PubTator, text mining | PubMed |
| Utility of Comprehensive Genomic Profiling Tests for Patients with Incurable Pancreatic Cancer in Clinical Practice. | Cancers (Basel) | 2023 | 36765927 | PubTator, text mining | PubMed |
| Genetics, Genomics and Emerging Molecular Therapies of Pancreatic Cancer. | Cancers (Basel) | 2023 | 36765737 | PubTator, text mining | PubMed |
| Current and Future Landscape of Perioperative Treatment for Muscle-Invasive Bladder Cancer. | Cancers (Basel) | 2023 | 36765525 | PubTator, text mining | PubMed |
| Identification of tumor antigens and immune landscapes for bladder urothelial carcinoma mRNA vaccine. | Front Immunol | 2023 | 36761744 | PubTator, text mining | PubMed |
| Homologous recombination inquiry through ovarian malignancy investigations: JGOG3025 Study. | Cancer Sci | 2023 | 36747324 | PubTator, text mining | PubMed |
| The effect of orthodontic treatment on smile attractiveness: a systematic review. | Prog Orthod | 2023 | 36740663 | PubTator, text mining | PubMed |
| Incarcerated left-sided Amyand's hernia and synchronous ipsilateral femoral hernia: first case report. | Surg Case Rep | 2023 | 36723671 | PubTator, text mining | PubMed |
| Evaluation of inherited germline mutations in cancer susceptibility genes among pancreatic cancer patients: a single-center study. | Mol Med | 2023 | 36717774 | PubTator, text mining | PubMed |
| A novel RAD51 variant resulting in Fanconi anemia identified in an infant with multiple congenital anomalies. | Clin Case Rep | 2023 | 36698515 | PubTator, text mining | PubMed |
| A CRISPR-Cas9 screen identifies EXO1 as a formaldehyde resistance gene. | Nat Commun | 2023 | 36693839 | PubTator, text mining | PubMed |
| Research on sand body architecture at the intersection of a bidirectional sedimentary system in the Jiyuan area of Ordos Basin. | Sci Rep | 2023 | 36681731 | PubTator, text mining | PubMed |
| Efficacy of Dabrafenib and Trametinib in a Patient with Squamous-Cell Carcinoma, with Mutation p.D594G in BRAF and p.R461* in NF1 Genes-A Case Report with Literature Review. | Int J Mol Sci | 2023 | 36674722 | PubTator, text mining | PubMed |
| Aplastic Anemia in Triple X Syndrome. | Children (Basel) | 2023 | 36670650 | PubTator, text mining | PubMed |
| Combining targeted DNA repair inhibition and immune-oncology approaches for enhanced tumor control. | Mol Cell | 2023 | 36669489 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2176/papers?page=16